Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Racial disparities in breast cancer diagnosis and treatment by hormone receptor and HER2 status.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology - 1 Nov 2015

Chen Lu, Li Christopher I

Abstract excerpt

BACKGROUND: African American and Hispanic women are more likely to be diagnosed with aggressive forms of breast cancer. Disparities within each subtype of breast cancer have not been well documented. METHODS: Using data from 18 SEER cancer registries, we identified 102,064 women aged 20 years or older, diagnosed with invasive breast cancer in 2010-2011, and with known stage, hormone receptor (HR), and HER2...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Asian
Share to Guideline Adherence

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Healthcare Disparities

Share to Hispanic or Latino

Share to Indians, North American

Share to Receptor, ErbB-2

Share to SEER Program

Share to Triple Negative Breast Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 26464428
DOI: 10.1158/1055-9965.EPI-15-0293
PMCID: PMC4633380

Genes

IMPACT

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Racial disparities in breast cancer diagnosis and treatment by hormone receptor and HER2 status.PMID 26464428Read ↗

Racial and ethnic differences in adjuvant hormonal therapy use.Semantic proximity Read ↗

Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry.Semantic proximity Read ↗

Breast cancer disparities in outcomes; unmasking biological determinants associated with racial and genetic diversity.Semantic proximity Read ↗

Biologic, demographic, and social factors affecting triple negative breast cancer outcomes.Semantic proximity Read ↗

Updated Biomarkers for TNBC in African vs. Caucasian American WomenSemantic proximity Read ↗

Outcome of African-American compared to White-American patients with early-stage breast cancer, stratified by phenotype.Semantic proximity Read ↗

Exploring Racial Differences in Pathological Complete Response to Neoadjuvant Chemotherapy and Pembrolizumab in Triple-Negative Breast CancerSemantic proximity Read ↗

Triple Negative Breast Tumors in African-American and Hispanic/Latina Women Are High in CD44+, Low in CD24+, and Have Loss of PTENSemantic proximity Read ↗

Age-related Differences in Breast Cancer Mortality according to Race/Ethnicity, Insurance, and Socioeconomic StatusSemantic proximity Read ↗

Comparison of the Genomic Landscape Between Primary Breast Cancer in African American Versus White Women and the Association of Racial Differences With Tumor Recurrence.Semantic proximity Read ↗

Histopathological and Clinical Features of HER2-Positive Breast Cancers across Hormone Receptor Subgroups: A Cross-Sectional AnalysisSemantic proximity Read ↗

Molecular Profiling of a Triple-negative Breast Cancer Cohort in India for EGFR and AR expression analyzed for patient outcomes showed a distinct subset of cellular co-expressionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.